Medication Optimization Among People With Type 2 Diabetes Participating in a Continuous Glucose Monitoring-Driven Virtual Care Program: Prospective Study.

Amit R Majithia^1,2, David M Erani³, Coco M Kusiak⁴, Jennifer E Layne⁵, Amy Armento Lee⁴, Francis R Colangelo⁶, Robert J Romanelli⁷, Scott Robertson⁴, Shayla M Brown⁵, Ronald F Dixon⁵, Howard Zisser⁴

¹Department of Medicine, University of California San Diego School of Medicine, La Jolla, CA, United States.

²Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, CA, United States.

³Onduo Professionals PC, Newton, MA, United States.

⁴Verily Life Sciences, South San Francisco, CA, United States.

⁵Onduo LLC, Newton, MA, United States.

⁶Allegheny Health Network, Monroeville, PA, United States.

⁷Sutter Health, Palo Alto, CA, United States.

PubMed PMC DOI PDF

Abstract

BACKGROUND: The Onduo virtual care program for people with type 2 diabetes (T2D) includes a mobile app, remote lifestyle coaching, connected devices, and telemedicine consultations with endocrinologists for medication management and prescription of real-time continuous glucose monitoring (RT-CGM) devices. In a previously described 4-month prospective study of this program, adults with T2D and base…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.